hackettg

Community Pharmacy England has prepared a new factsheet to help pharmacy owners maximise their income from dispensing. The factsheet includes top tips to help maximise income or reduce losses when: Dispensing Ordering Endorsing prescriptions Submitting claims/prescriptions for payment (including end-of-month MYS declaration) Reconciling payments against claims submitted The factsheet also links to a wealth of [...]

The post Top tips to maximise dispensing income appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, with the support of Novo Nordisk Ltd, the Department of Health of Social Care (DHSC) has re-determined the special container status of Rybelsus® (semaglutide) tablets. From 1 April 2024, all three strengths of Rybelsus® tablets (3mg, 7mg and 14mg) will be re-classified as special containers to be supplied as [...]

The post Rybelsus® tablets re-classified as a special container appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2024. Part VIIIA – Basic prices of drugs Contractors should note changes made to: Basic Price of Drugs covered by Part II Clause 8A [...]

The post Drug Tariff Watch – April 2024 appeared first on Community Pharmacy England.

From 1 April 2024, the pack size listings of Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension will be updated. This follows the identification by Community Pharmacy England of a discrepancy in the pack size listings for Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension. Currently, the pack sizes listed in the Drug Tariff and the NHS [...]

The post Changes to Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension pack sizes appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/09 Date issued: 19 March 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Oestrogel Pump-Pack 750 micrograms/actuation Gel (estradiol) (Besins Healthcare (UK) Ltd) PL 28397/0002 SNOMED Code: 3414911000001105 Batch No Expiry Date Pack Size First Distributed 74800 31/07/2026 1 06/11/2023 74830 31/08/2026 [...]

The post MHRA Class 3 Medicines Recall: Oestrogel Pump-Pack 750 micrograms/actuation Gel (estradiol) (Besins Healthcare (UK) Ltd) appeared first on Community Pharmacy England.